|
Long-Term Follow-Up Program
Resource Guide |
|
|
This comprehensive guide to establishing and enhancing long-term follow-up programs for childhood cancer survivors was developed collaboratively by the Children’s Oncology Group Nursing Discipline and Late Effects Committee. Over 50 individuals from multiple disciplines contributed to this Long-Term Follow-Up Program Resource Guide, providing a broad perspective from a variety of long-term follow-up programs within the Children’s Oncology Group. |
|
|
Click here to download PDF (free)
Click here to order softbound full-color copy
|
|
The Children’s Oncology Group Long-Term
Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young
Adult Cancers were developed as a collaborative effort of the
Nursing Discipline and the Late Effects Committee and are maintained and updated by the Children’s Oncology Group’s Long-Term Follow-Up Guidelines Core Committee and its associated Task Forces. The purpose of these
guidelines is to provide recommendations for screening and management
of late effects that may potentially arise as a result of therapeutic
exposures used during treatment for pediatric malignancies. These
guidelines represent a statement of consensus from a panel of experts
in the late effects of pediatric cancer treatment. The recommendations
are based on a thorough review of the literature as well as the
collective clinical experience of the task force members, panel of
experts, and multidisciplinary review panel (including nurses,
physicians, behavioral specialists and patient/parent advocates).
Implementation of these guidelines is intended to increase awareness of
potential late effects and to standardize and enhance follow-up care
provided to survivors of pediatric malignancies throughout the
lifespan.
The Long-Term Follow-Up Guidelines
were developed as a resource for clinicians who provide ongoing
healthcare to survivors of pediatric malignancies. A basic knowledge of
ongoing issues related to the long-term follow-up needs of this patient
population is assumed. The screening recommendations in these
guidelines are appropriate for asymptomatic survivors of childhood,
adolescent, or young adult cancer presenting for routine exposure-based
medical follow-up. More extensive evaluations are presumed, as
clinically indicated, for survivors presenting with signs and symptoms
suggesting illness or organ dysfunction.
The
current version of these Guidelines is Version 3.0 – October 2008.
As new information becomes available, the guidelines will be updated
periodically to reflect those changes. We recommend that clinicians
check this website periodically for the latest updates and revisions.
Healthcare professionals who do not regularly care for survivors of
pediatric malignancies are encouraged to consult with a pediatric
oncology long-term follow-up center if any questions or concerns arise
when reviewing or using these guidelines. These guidelines are not
intended to replace clinical judgment or to exclude other reasonable
alternative follow-up procedures. The Children’s Oncology
Group recognizes that specific patient care decisions are the
prerogative of the patient, family, and healthcare provider.
Although the information within the guidelines
will certainly prove valuable to the survivors themselves, at this time
the only version available is targeted to healthcare professionals.
Therefore, survivors who choose to review these guidelines are strongly
encouraged to do so with the assistance of a healthcare professional
knowledgeable about long-term follow-up care for survivors of
childhood, adolescent, and young adult cancers. This is important in
order to put the recommendations in perspective, avoid over-testing,
address potential anxieties, and provide a comprehensive evaluation of
the survivor’s health status. The Children’s
Oncology Group itself does not provide individualized treatment advice
to patients or their families, and strongly recommends discussing this
information with a qualified medical professional.
In addition to the PDF files available below, which are downloadable free of charge, the COG Long-Term Follow-Up Guidelines are also available for purchase in a printed, spiral-bound format. Click here to order.
|
|
The Children’s Oncology Group grants permission to download
the Children's Oncology Group Long-Term Follow-Up Guidelines
for Survivors of Childhood, Adolescent, and Young Adult Cancers
(including Appendices, Materials for Clinical Application, and Health Links) from
www.survivorshipguidelines.org and to print copies for individual and
institutional use, as long as the following conditions are met: (1)
Copies are not sold or distributed for commercial advantage, and (2)
the Children's Oncology Group copyright and its date appear on the
printed copies.
Disclaimer and Notice of Proprietary
Rights:
Introduction to Late Effects Guidelines and Health
Links: The "Long-Term Follow-Up Guidelines for Survivors of
Childhood, Adolescent and Young Adult Cancers" and accompanying "Health
Links" were developed by the Children's Oncology Group as a
collaborative effort of the Late Effects Committee and Nursing
Discipline and are maintained and updated by the Children’s Oncology Group’s Long-Term Follow-Up Guidelines Core Committee and its associated Task Forces.
For Informational Purposes Only:
The information and contents of this website (including all text and
graphics), the information and contents of each document or series of
documents posted on this website or containing the title "Long-Term
Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young
Adult Cancers " or the title "Health Link", whether available in print
or electronic format (including any digital format, e-mail
transmission, or download from the website), shall be known hereinafter
as "Site Content". All Site Content is for informational purposes only.
The Site Content is not intended to substitute for medical advice,
medical care, diagnosis or treatment obtained from a physician or
health care provider.
To cancer patients (if
children, their parents or legal guardians): Please seek the
advice of a physician or other qualified health provider with any
questions you may have regarding a medical condition and do not rely on
the Site Content. The Children's Oncology Group is a research
organization and does not provide individualized medical care or
treatment.
To physicians and other healthcare
providers: The Site Content is not intended to replace your
independent clinical judgment, medical advice, or to exclude other
legitimate criteria for screening, health counseling, or intervention
for specific complications of childhood cancer treatment. Neither is
the Site Content intended to exclude other reasonable alternative
follow-up procedures. The Site Content is provided as a courtesy, but
not intended as a sole source of guidance in the evaluation of
childhood cancer survivors. The Children's Oncology Group recognizes
that specific patient care decisions are the prerogative of the
patient, family, and healthcare provider.
No endorsement of any specific tests, products, or procedures is made
by Site Content, the Children's Oncology Group, or affiliated party or
member of the Children's Oncology Group.
No Claim to Accuracy or Completeness:
While the Children's Oncology Group has made every attempt to assure
that the Site Content is accurate and complete as of the date of
publication, no warranty or representation, express or implied, is made
as to the accuracy, reliability, completeness, relevance, or timeliness
of such Site Content.
No Liability on Part of Children's
Oncology Group and Related Parties/ Agreement to Indemnify and Hold
Harmless the Children's Oncology Group and Related Parties:
No liability is assumed by the Children's Oncology Group or any
affiliated party or member thereof for damage resulting from the use,
review, or access of the Site Content. You agree to the following terms
of indemnification: (i) "Indemnified Parties" include authors and
contributors to the Site Content, all officers, directors,
representatives, employees, agents, and members of the Children's
Oncology Group and affiliated organizations; (ii) by using, reviewing,
or accessing the Site Content, you agree, at your own expense, to
indemnify, defend and hold harmless Indemnified Parties from any and
all losses, liabilities, or damages (including attorneys' fees and
costs) resulting from any and all claims, causes of action, suits,
proceedings, or demands related to or arising out of use, review, or
access of the Site Content.
Proprietary Rights: The
Site Content is subject to protection under copyright law and other
intellectual property protection law in the United States and
worldwide. The Children's Oncology Group retains excusive copyright and
other right, title, and interest to the Site Content and claims all
intellectual property rights available under law. You hereby agree to
help the Children's Oncology Group secure all copyright and
intellectual property rights for the benefit of the Children's Oncology
Group by taking additional action at a later time, action which could
include signing consents and legal documents and limiting dissemination
or reproduction of the Site Content.
|